HAPPEL DAVID (President & CEO) received a stock award from SAGIMET BIOSCIENCES INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/7/2025ACC: 0001104659-25-010587
DirectorOfficer· President & CEO
Since Feb 2026
+588K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
588K acquired
Non-Derivative Transactions1
Series A Common Stock
Direct
Shares
+116K
Price / share
—
Trade value
—
% of position
18.1%
2/6/2025
639.20K→755.20K
Total
Net shares
+116K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Series A Common Stock Direct | 2/6/2025 | A · Award | +116K | — | — | 18.1% | 639.20K | 755.20K |
| Total | +116K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Series A Common Stock
472K shares
Shares
+472K
Strike price
4.71
Held after
472K
Exercisable
—
2/6/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Series A Common Stock472K shares | 2/6/2025 | A · Award | +472K | 4.71 | — | 472K |